Robust Acenaphthoimidazolylidene Palladacycles: Highly Efficient Catalysts for the Amination of N-Heteroaryl Chlorides.

about

Robust Acenaphthoimidazolylidene Palladacycles: Highly Efficient Catalysts for the Amination of N-Heteroaryl Chlorides.

Item

http://www.wikidata.org/entity/Q48107229

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Robust Acenaphthoimidazolylide ...... ion of N-Heteroaryl Chlorides.

@en

Robust Acenaphthoimidazolylide ...... ion of N-Heteroaryl Chlorides.

@nl

type

Item

label

Robust Acenaphthoimidazolylide ...... ion of N-Heteroaryl Chlorides.

@en

Robust Acenaphthoimidazolylide ...... ion of N-Heteroaryl Chlorides.

@nl

prefLabel

Robust Acenaphthoimidazolylide ...... ion of N-Heteroaryl Chlorides.

@en

Robust Acenaphthoimidazolylide ...... ion of N-Heteroaryl Chlorides.

@nl

P1476

Robust Acenaphthoimidazolylide ...... tion of N-Heteroaryl Chlorides

@en

P2093

Qinyue Deng

http://www.w3.org/2001/XMLSchema#string

Yang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Highly efficient aminocarbonylation of iodoarenes at atmospheric pressure catalyzed by a robust acenaphthoimidazolyidene allylic palladium complex.

Rational exploration of N-heterocyclic carbene (NHC) palladacycle diversity: a highly active and versatile precatalyst for Suzuki-Miyaura coupling reactions of deactivated aryl and alkyl substrates.

Pd-catalyzed N-arylation of secondary acyclic amides: catalyst development, scope, and computational study

Dialkylbiaryl Phosphines in Pd-Catalyzed Amination: A User's Guide.

A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.

Rosiglitazone : a review of its use in type 2 diabetes mellitus.

Impact of natural products on developing new anti-cancer agents.

N-Heterocyclic carbene (NHC) ligands and palladium in homogeneous cross-coupling catalysis: a perfect union.

The background, discovery and clinical development of BCR-ABL inhibitors.

Acridine and its derivatives: a patent review (2009 - 2013).

P304

2364-2368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ASIA.201700877

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Haibo Zhu

Tao Tu

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28719728

http://www.w3.org/2001/XMLSchema#string